Lenacapavir Related Compounds & Impurities

Lenacapavir is a first-in-class long-acting HIV capsid inhibitor administered subcutaneously every six months for multidrug-resistant HIV-1.

Simson Pharma Limited along with its subsidiary offices Simson Pharma Global Ltd. (UK) and Simson Pharma Global LLC (USA) is a trusted manufacturer and supplier of high-quality pharmaceutical reference standards, offering a comprehensive portfolio of Lenacapavir reference standards, pharmacopeial and non-pharmacopeial Lenacapavir impurities, related compounds, related substances, metabolites, stable isotope-labelled compounds, deuterium labelled compounds and nitrosamine (N-NO) reference standards.

These materials support pharmaceutical research and development, product development, ANDA and DMF submissions, quality control (QC), analytical method development and validation, stability studies, impurity identification, and genotoxic impurity assessment.

Our Lenacapavir-related reference standards are thoroughly characterized using advanced analytical techniques and are supplied with comprehensive Certificates of Analysis (COA) and supporting analytical data from our USFDA certified, ISO 17025 and ISO 17034 accredited Lab, to meet global regulatory expectations. EP and USP traceable reference standards can also be provided upon request, subject to availability. Simson is also a provider of EP and USP traceable standards. To ensure consistent quality and reliability, our reference standards are periodically re-tested according to established quality management procedures.

Pharmaceutical Reference Standards / Impurity Standards

Lenacapavir
Lenacapavir Impurity 4
Lenacapavir Impurity 5
Lenacapavir Impurity 6
Lenacapavir Impurity 1
Lenacapavir Impurity 7
Lenacapavir Impurity 8
Lenacapavir Impurity 9
Lenacapavir Impurity 10
Lenacapavir Impurity 11
Lenacapavir Impurity 12
Lenacapavir Impurity 13
Lenacapavir Impurity 14
Lenacapavir Impurity 15
Lenacapavir Impurity 17
Lenacapavir Impurity 18
Lenacapavir Impurity 19
Lenacapavir Impurity 20
Lenacapavir Impurity 21
Lenacapavir Impurity 22
Lenacapavir Impurity 23
Lenacapavir Impurity 24
Lenacapavir Impurity 25
Lenacapavir Impurity 26
Lenacapavir Impurity 27
enacapavir Impurity 28
Lenacapavir Impurity 29
Lenacapavir Impurity 30
Lenacapavir Impurity 31
Lenacapavir Impurity 32
Lenacapavir Impurity 33
Lenacapavir Impurity 34
Lenacapavir Impurity 35
Lenacapavir Impurity 36
Lenacapavir Impurity 37
Lenacapavir Impurity 38
Lenacapavir Impurity 39
Lenacapavir Impurity 40
Lenacapavir Impurity 41
Lenacapavir Impurity 42
Lenacapavir Impurity 43
Lenacapavir Impurity 44
Lenacapavir Impurity 45
Lenacapavir Impurity 46
Lenacapavir Impurity 47
Lenacapavir Impurity 48
Lenacapavir Impurity 49
Lenacapavir Impurity 50
Lenacapavir Impurity 51
Lenacapavir Impurity 52
Lenacapavir Impurity 53
Lenacapavir Impurity 54
Lenacapavir Impurity 55
Lenacapavir Impurity 56
Lenacapavir Impurity 2
Lenacapavir Impurity 3
Lenalidomide Impurity 61
Lenacapavir Impurity 59
Lenacapavir Impurity 60
Lenacapavir Impurity 61
Lenacapavir Impurity 62
Lenacapavir Impurity 16
Lenacapavir (R)-Isomer
Lenacapavir Impurity 28
Lenacapavir Impurity 58
Lenacapavir Impurity 63
Lenacapavir Impurity 64
Lenacapavir Impurity 65
Lenacapavir Impurity 66
Lenacapavir Impurity 67
Lenacapavir Impurity 68
Lenacapavir Impurity 69
Lenacapavir Impurity 57
Lenacapavir Impurity 70
Lenacapavir impurity 71
Lenacapavir impurity 72
Lenacapavir Impurity 73
Lenacapavir Impurity 74
Lenacapavir Impurity 75
Lenacapavir Impurity 76
Lenacapavir Impurity 77
Lenacapavir Impurity 78
Lenacapavir Impurity 79

Isotope Labelled Compounds

Lenacapavir D5